OKYO Pharma Limited (NASDAQ:OKYO) Sees Large Growth in Short Interest

OKYO Pharma Limited (NASDAQ:OKYO) was the target of a significant growth in short interest in February. As of February 28th, there was short interest totalling 338,000 shares, a growth of 30.4% from the February 13th total of 259,200 shares. Approximately 1.4% of the company’s stock are short sold. Based on an average daily trading volume, of 150,800 shares, the days-to-cover ratio is currently 2.2 days.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a “buy” rating and issued a $7.00 price target on shares of OKYO Pharma in a research note on Tuesday, February 18th.

OKYO Pharma Trading Down 4.4 %

OKYO Pharma stock traded down $0.07 during midday trading on Tuesday, reaching $1.43. 20,684 shares of the company’s stock were exchanged, compared to its average volume of 123,065. The stock’s 50-day simple moving average is $1.17 and its 200 day simple moving average is $1.10. OKYO Pharma has a 52 week low of $0.81 and a 52 week high of $1.90.

OKYO Pharma Company Profile

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.